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Abstract: Thirty-two canine mammary tubulopapillary carcinomas and 14 simple adenomas were studied by im-
munohistochemistry for the expression of UDP-galactose:ceramide galactosyltransferase (UGT8). The majority 
of tissue specimens (57%) representing adenomas had no or weak reaction with anti-UGT8 antibodies (0-2 pts 
according to IRS scale) in comparison to the majority of carcinomas (90%) which stained with high intensities 
(3-9 pts according to IRS scale). When the average values of the reaction intensities (IRS) for malignant and 
benign tumors were compared, using the Mann-Whitney U-test, significant differences in UGT8 expression be-
tween them were found (P < 0.001). Mammary tubulopapillary carcinomas were further analyzed by IHC and 
the same rabbit polyclonal antibody directed against UGT8 according to their malignancy grade. It was found 
that the level of UGT8 increased in tumor specimens together with their grading. A comparison of the average 
values of the reaction intensity (IRS scale) revealed a significant difference (Mann-Whitney U-test, P < 0.05) in 
UGT8 expression between tumors representing malignancy grades G3 and G1. Based on the obtained results, it 
is proposed that UGT8 is associated with malignancy of canine mammary gland cells and may have a potential 
value as a diagnostic marker. (Folia Histochemica et Cytobiologica 2013, Vol. 51, No. 2, 164–167)
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Introduction
UDP-galactose:ceramide galactosyltransferase 
(UGT8, CGT, C.E. 2.4.2.62) is the enzyme involved 
in the synthesis of galactosylceramide (GalCer) which 
is the major glycosphingolipid of myelin produced by 
oligodendrocytes in the central nervous system and 
Schwann cells in the peripheral nervous system [1–4]. 
It was suggested that GalCer is involved in myelin 
function and stability but not in its biogenesis [5–7]. 
This glycosphingolpid is also present in other organs 
such as the kidney, small intestine, colon, liver, and 
testis [8–11].
It has been shown recently that UGT8 is one 
of six genes which an elevated level correlates with 
a highly increased risk of lung metastases in breast 
cancer patients [12]. Also, elevated expression of 
UGT8 gene in breast cancer was significantly asso-
ciated with negative expression of estrogen receptors 
165UGT8 in canine mammary tumor
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2013
10.5603/FHC.2013.0024
www.fhc.viamedica.pl
(ER-negativity), and therefore with a more malignant 
phenotype [13, 14]. Studies performed on the level 
of mRNA expression using microarray analysis and 
quantitative RT-PCR were further confirmed by 
immunohistochemistry. It has been shown that high 
expression of UGT8 protein is a significant index of 
tumor aggressiveness and a potential marker for the 
prognostic evaluation of lung metastases in breast 
cancer [15]. So far, there were no reports about 
the expression of UGT8 in canine mammary gland 
tumors, therefore, the present study was undertaken 
to analyses the expression of this enzyme in malignant 
and benign canine tumors.
Material and methods
Tissue specimens. Tissue specimens were obtained from 
46 female dogs of different pure and mixed breeds, aged 
7 to 15 years, undergoing surgery at the Department of 
Surgery, Faculty of Veterinary Medicine, University of 
Environmental and Life Sciences, Wroclaw, Poland. The 
tumors were removed with a margin of approximately 2 cm 
of healthy tissues. 
Histopathological examination and immunohistochemical 
reactions (IHC). For histological examination the tumor 
specimens were fixed in 10% neutral-buffer (7.0–7.4 pH) 
formalin and embedded in paraffin. Paraffin sections, 
mounted on Superfrost slides were dehydrated and stained 
with hematoxylin and eosin. The tumors were classified on 
the basis of the diagnostic criteria of the World Health Or-
ganization [16]. Malignant tumors were classified according 
to the Bloom-Richardson scale modified by Elston and Ellis 
[17]. The method for the evaluation of the malignancy grade 
included three parameters scored in the scale from 0 to 3 
points: formation of tubules (evident, moderate, slight), 
polymorphism of cell nuclei (slight, moderate, marked), 
number of mitotic figures per 10 microscope fields at the 
magnification of ×400 (0–7, 8–16, ≥ 17). The sum of the po-
ints provided potential to distinguish 3 grades of malignancy 
(G) among the tumors: 0–5 pts. — G1 grade, 6–7 pts. — G2 
grade, 8–9 pts. — G3 grade. Immunohistochemical staining 
was performed on 4-µm-thick paraffin sections. First, the 
sections were deparaffinized in xylene and gradually rehy-
drated using ethanol. Antigen retrieval was performed by 
boiling the tissue sections in Antigen Retrieval Solution (pH 
9, 97°C, 20 min; Dako, Glostrup, Denmark). Endogenous 
peroxidase activity was blocked by 5 min. incubation with 
3% H2O2. Then the sections were incubated with a primary 
rabbit polyclonal antibody directed against UGT8 (Atlas 
Prestige Antibodies, Stockholm, Sweden) diluted in Bac-
kground Reducing Antibody Diluent (Dako) for 1 h at 
room temperature. Peroxidase conjugated goat secondary 
antibodies (EnVision/HRP; Dako) and diaminobenzidine 
tetrachloride (DAB; Dako) were used to visualize the 
studied antigen. All tissue sections were counter-stained 
with Mayer’s hematoxylin. As positive control for the 
UGT8 IHC a previously breast cancer specimen charac-
terized by its high expression in cancer cells was utilized, 
whereas Primary Negative Control (Dako) was used as 
the negative control [15].
Evaluation of IHC reactions. The IHC sections were eva-
luated using BX-53 light microscope (Olympus, Tokyo, 
Japan) by two independent pathologists. The level of UGT8 
expression was ranked using the modified semi-quantita-
tive Immunoreactive Remmele Score (IRS) according to 
Remmele and Stegner (Table 1) [18]. This method takes 
into account both the proportion of stained cells and the 
intensity of the reaction, while its final results represent the 
product of the two parameters, with values ranging from 
0 to 12 points (no reaction = 0 points, weak reaction = 1– 
–2 points, moderate reaction = 3–4 points and intense 
reaction = 6–12 points). 
Statistical analysis. When groups of data were compared, 
but failed to satisfy the assumptions of the parametric test, 
the Mann-Whitney U-test, the non-parametric equivalent 
of Student’s t-test, was used. The results were considered 
statistically significant when P < 0.05 in both analysis. So-
ftware Statistica 7.1 (STATSoft, Cracow, Poland) was used 
for all analyses.
Table 1. Semiquantitative IRS scale taking into account both the percentage of positive cells (A) and the intensity of the 
reaction color (B), with the final score representing the product of the two variables (A × B)
Point score A B
0 No cells with positive reaction  No color reaction
1 ≤ 10% Cells with positive reaction  Low intensity of color reaction
2 11–50% Cells with positive reaction  Average intensity of color reaction
3 51–80% Cells with positive reaction  Intense color reaction
4 > 80% Cells with positive reaction
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On the basis of histological examination, 32 mammary 
tubulopapillary carcinomas and 14 simple adenomas 
were included in the present study. The primary 
carcinomas were further classified according to the 
Bloom-Richardson modified by Elston and Ellis [17] 
as G1 (14 cases), G2 (11 cases) and G3 (7 cases).
Expression of UGT8 in the paraffin sections of 
malignant and benign tumors was analyzed using 
rabbit polyclonal antibodies directed against human 
UGT8 (Figure 1A and B). The majority of tissue 
specimens (57%) representing adenomas had no or 
weak reaction with anti-UGT8 antibodies (0–2 pts 
according to IRS scale) in comparison to the ma-
jority of carcinomas (90%) which stained with high 
intensities (3–9 pts according to IRS scale). When 
the average values of the reaction intensities (IRS) 
for malignant and benign tumors were compared 
by the Mann-Whitney U-test, significant differen-
ces in UGT8 expression between them were found 
(P < 0.001, Figure 1C). Mammary tubulopapillary car-
cinomas were further analyzed by IHC and the same 
rabbit polyclonal antibody directed against UGT8 
according to their malignancy grade. It was found that 
the level of this antigen increased in tumor specimens 
together with their grading. The average values of 
the reaction intensity (IRS scale) were significantly 
different (Mann-Whitney U-test, P < 0.05) in UGT8 
expression between tumors representing malignancy 
grades G3 and G1 (Figure 2).
Discussion 
Based on the results obtained for human breast cancer 
(Dziegiel et al., 2010), the intensities of UGT8 staining 
in node-positive and node-negative tumors were also 
compared. Node-positive cases were characterized by 
a higher average IRS value (5.25 ± 1.91) than node-
negative cases (4.45 ± 2.09). However, this difference 
was not significant (data not shown).
It has been shown recently that expression of 
UGT8 is highly elevated in breast cancer metastases 
to the lung in comparison to matched primary tumors 
and increased expression of this enzyme are associa-
ted with progression to a more malignant phenotype 
[12–15]. Based on these results we studied the expres-
sion of UGT8 in canine tubulopapillary carcinomas 
and simple adenomas. Our results showed that canine 
malignant tumors had much higher expression of 
UGT8 in comparison to benign tumors. As in humans, 
an elevated expression of UGT8 correlated with pro-
gression to a more malignant phenotype. Therefore, 
our data show that UGT8 expression is associated 
with canine mammary carcinoma and could represent 
a potentially new marker of malignancy and tumor 
aggressiveness in dogs.
Figure 1. Immunohistochemical staining of (A) simple ade-
noma and (B) canine mammary tubulopapillary carcinoma 
with anti-UGT8 rabbit polyclonal antibodies. Reaction 
intensities with rabbit polyclonal antibodies for UGT8 (C) 
were calculated on the basis of the semiquantitative IRS 
scale of Remmele and Stegner (1987) and are represented 
as means: *P < 0001 for mammary tubulopapillary carcino-
mas (n =32) as compared with adenomas (n =14) (Mann
-Whitney U-test)
Figure 2. UGT8 expression in canine mammary tubulopa-
pillary carcinomas of different malignancy grades: G1  
(n =14), G2 (n =11) and G3 (n =7). Reaction intensities 
with rabbit polyclonal antibodies for UGT8 were calculated 
on the basis of the semiquantitative IRS scale of Remmele 
and Stegner (1987) and are represented as means:  
*P < 0.05 for carcinomas of grade G3 as compared with 
carcinomas of grade G1 (Mann-Whitney U-test)
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The question remains as to the biological meaning 
of increased expression of UGT8. This enzyme is 
involved in the biosynthesis of GalCer, and it is pos-
sible that in human cancer, including breast cancer, 
an accumulation of this glycosphingolipid in tumor 
cells inhibits apoptosis, which facilitates metastatic 
cells to survive in the hostile micro-environment of 
the target organ [15,19]. Breast tumors and canine 
mammary neoplasia have many features in common. 
Both of them are age- and hormone-dependent, and 
are often similar in their histological appearance as 
well as the expression of molecular markers [20–23]. 
Therefore we suggest that GalCer, similarly to hu-
mans, may have an antiapoptotic function in canine 
mammary tumors. However, this hypothesis needs 
further functional studies.
In summary, our data suggest that UGT8 expres-
sion is associated with degree of malignancy of canine 
mammary gland tumors and may be of potential value 
as a diagnostic marker.
References
1. Kapitonov D, Yu RK. Cloning, characterization, and 
expression of human ceramide galactosyltransferase cDNA. 
Biochem Biophys Res Commun. 1997;232:449–453. 
2. Schulte S, Stoffel W. Ceramide UDP galactosyltransferase 
from myelinating rat brain: purification, cloning and expres-
sion. Proc Natl Acad Sci U.S.A. 1993;90:10265–10269.
3. Sprong H, Kruithof B, Leijendekker R et al.  UDP-galacto-
se:ceramide galactosyltransferase is a class I integral mem-
brane protein of the endoplasmic reticulum. J Biol Chem. 
1998;273:25880–25888. 
4. Marcus J, Popko B. Galactolipids are molecular determinants 
of myelin development and axo-glial organization. Biochim 
Biophys Acta. 2002;1573:406–413. 
5. Bosio A, Binczek E, Stoffel W. Functional break-down of the 
lipid bilayer of the myelin membrane in central and peripheral 
nervous system by disrupted galactosylcerebroside synthesis. 
Proc Natl Acad Sci U.S.A. 1996;93:13280–13285. 
6. Coetzee T, Fujita N, Dupree J et al. Myelination in the 
absence of galactosylcerebroside and sulfatide: normal 
structure with abnormal function and regional instability. 
Cell. 1996;86:209–219. 
7. Dupree JL, Girault J, Popko B. Axo-glial interactions regu-
late the localization of axonal paranodal proteins. J Cell Biol. 
1999;147:1145–1151. 
8. Kodama S, Igisu H, Siegel D et al. Glycosylceramide synthe-
sis in the developing spinal cord and kidney of the twitcher 
mouse, an enzymatically authentic model of human Krabbe 
disease. J Neurochem. 1982;39:1314–1318. 
9. Natomi H, Saitoh T, Sugano K et al. Systematic analysis of 
glycosphingolipids in the human gastrointestinal tract: enrich-
ment of sulfatides with hydroxylated longer-chain fatty acids 
in the gastric and duodenal mucosa. Lipids. 1993;28:737–742. 
10. Nilsson O, Svennerholm L. Characterization and quantitative 
determination of ganglioside and neutral glycosphingolipids 
in human liver. J Lipid Res. 1982;23:327–334. 
11. Vos JP, Lopes-Cardozo M, Gadella BM. Metabolic and 
functional aspects of sulfogalactolipids. Biochim Biophys Acta. 
1994;1211:125–149. 
12. Landemaine T, Jackson A, Bellahcene A et al. A six-gene 
signature predicting breast cancer lung metastasis. Cancer 
Res. 2008;68:6092–6099. 
13. Ruckhaberle E, Rody A, Engels K et al. Microarry analysis 
of altered sphingolipid metabolism reveals prognostic signifi-
cance of sphingosine kinase 1 in breast cancer. Breast Cancer 
Res Treat. 2008;112:41–52. 
14. Yang F, Foekens JA, Yu J, Sieuwerts AM et al. Laser 
microdissection and microarray analysis of breast tumors 
reveal ER-alpha related genes and pathways. Oncogene. 
2006;25:1413–1419. 
15. Dziegiel P, Owczarek T, Plazuk E et al. Ceramide galac-
tosyltransferase (UGT8) is a molecular marker of breast 
cancer malignancy and lung metastases. Br J Cancer. 
2010;103:524–531. 
16. Misdorp W, Else RW, Hellmen E et al. Histological clas-
sification of the mammary tumors of the dog and the cat. 
In: World Health Organization  International Histological 
Classification of Tumors of Domestic Animals, 2nd series, vol. 
7. AFIP, Washington, DC, 1999:1–59
17. Elston CW, Ellis IO. Pathological prognostic factors in breast 
cancer:experience from a large study with long-term follow
-up. Histopathology. 1991;19:403–410. 
18. Remmele W, Stegner HE. Vorschlag zur einheitlichen Defini-
tion eines immunreaktiven Score (IRS) fuer den immunohis-
tochemischen Ostrogenrezeptor-Nachweis (ER-ICA) im 
Mammakarzinomgewebe. Pathologe. 1987;8:138–140. 
19. Beier UH, Gorogh T. Implications of galactosylcerebrosidase 
and galactosylcerebroside metabolism in cancer cells. Int J 
Cancer. 2005;115:6–10. 
20. Cotran RS, Kumar V, Robbins SL et al. The breast. In: Pa-
thologic Basis of Disease, ed. Cotran RS, Kumar V, Robbins 
SL, and Schoen FJ, 5th ed. WB Saunders, Philadelphia, PA, 
1994:1089–1111.
21. Schulte S, Stoffel W. Ceramide UDP galactosyltransferase 
from myelinating rat brain: purification, cloning and expres-
sion. Proc Natl Acad Sci. U.S.A. 1993;90:10265–10269. 
22. Sprong H, Kruithof B, Leijendekker R et al. UDP-galacto-
se:ceramide galactosyltransferase is a class I integral mem-
brane protein of the endoplasmic reticulum. J Biol Chem. 
1998;273:25880–25888. 
23. Nowak M, Madej J, Dziegiel P et al. Tumor-associated car-
bohydrate antigens: sialyl Lea and T/Tn antigens in canine 
mammary tumors. Vet Pathol. 2009;46:222–226.
Submitted: 6 February, 2013 
Accepted after reviews: 27 May, 2013
